![](/img/cover-not-exists.png)
Aneustat (OMN54) has aerobic glycolysis-inhibitory activity and also immunomodulatory activity as indicated by a first-generation PDX prostate cancer model
Qu, Sifeng, Xue, Hui, Dong, Xin, Lin, Dong, Wu, Rebecca, Nabavi, Noushin, Collins, Colin C., Gleave, Martin E., Gout, Peter W., Wang, YuzhuoLanguage:
english
Journal:
International Journal of Cancer
DOI:
10.1002/ijc.31310
Date:
February, 2018
File:
PDF, 1.38 MB
english, 2018